{
    "id": "dbpedia_8013_1",
    "rank": 79,
    "data": {
        "url": "https://www.statista.com/outlook/hmo/pharmaceuticals/united-kingdom",
        "read_more_link": "",
        "language": "en",
        "title": "Pharmaceuticals - United Kingdom",
        "top_image": "https://cdn.statcdn.com/static/img/openGraph/xmo/openGraph-hmo-en.png",
        "meta_img": "https://cdn.statcdn.com/static/img/openGraph/xmo/openGraph-hmo-en.png",
        "images": [
            "https://cdn.statcdn.com/Study/160000/162257-standard.png",
            "https://cdn.statcdn.com/static/img/outlook/methodology-cover.png",
            "https://cdn.statcdn.com/static/img/worldmap.svg",
            "https://cdn.statcdn.com/contactPerson/3646.jpg",
            "https://cdn.statcdn.com/contactPerson/3195.jpg",
            "https://cdn.statcdn.com/contactPerson/2661.jpg",
            "https://cdn.statcdn.com/contactPerson/863.jpg",
            "https://cdn.statcdn.com/contactPerson/3012.jpg"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "The Pharmaceuticals market [geoPrepName] is projected to grow by 5.75% (2024-2029) resulting in a market volume of US$41.34bn in 2029.",
        "meta_lang": "en",
        "meta_favicon": "https://cdn.statcdn.com/static/favicon.svg",
        "meta_site_name": "Statista",
        "canonical_link": "https://www.statista.com/outlook/hmo/pharmaceuticals/united-kingdom",
        "text": "Definition:\n\nThe Pharmaceuticals market covers remedies used to cure, treat, prevent, and diagnose diseases. These small molecule drugs or biologic medical products may be called drugs, medications, or medicines. Prescription drugs and over-the-counter (OTC) drugs are both included. Depending on the regulations in each country, these products are provided by pharmacies, hospitals, physicians, and/or drug stores, and/or they can be bought elsewhere. They may be administered in the form of pills, capsules, gels, ointments, injections, infusions, lozenges, or aerosols/sprays.\n\nStructure:\n\nThe market is subdivided into Oncology Drugs, Anti-Diabetes Drugs, Anti-Rheumatic Drugs, Vaccines, Dermatological Drugs, Antiviral Drugs, Immunosuppressants, Bronchodilator Drugs, Sensory Organ Drugs, Anti-Hypertensive Drugs, Anti-Coagulants, Anti-Fibrinolytic Drugs, Multiple Sclerosis Drugs, Lipid-Lowering Agents and Other Pharmaceuticals. The Pharmaceuticals market is organized in markets that cover drugs used in specific medical fields, i.e., medicines for a specific disesase or a certain type of medicine. They include original brands, biosimilars, generics, and orphan drugs.The Oncology Drugs market covers pharmaceutical products specifically developed for the treatment and management of various cancers. The Anti-Diabetes Drugs market covers medications designed to manage blood glucose levels and improve insulin sensitivity in individuals with diabetes. The market Anti-Rheumatic Drugs includes pharmaceuticals specifically developed to alleviate symptoms, reduce inflammation, and modify the progression of rheumatic diseases. The Dermatological Drugs market covers pharmaceuticals formulated to treat and manage a wide range of skin conditions such as eczema, acne, and rosacea. The Antiviral Drugs market includes medications designed to treat viral infections and reducing the severity and duration of symptoms. The Immunosuppressants market covers pharmaceuticals that suppress the immune system's activity. The Bronchodilator Drugs market covers pharmaceuticals designed to relax and widen the airways in the lungs. The Sensory Organ Drugs market covers pharmaceuticals targeting the treatment of disorders and conditions affecting sensory organs such as the eyes, ears and nose. The Anti-hypertensive Drugs market covers pharmaceuticals designed to lower blood pressure levels. The Anti-Coagulants Drugs market covers pharmaceuticals developed to prevent the formation of blood clots or to dissolve existing clots. The Anti-Fibrinolytics Drugs market covers pharmaceuticals designed to inhibit the breakdown of blood clots. The Multiple Sclerosis Drugs market covers pharmaceuticals aimed at managing and modifying the course of multiple sclerosis. The Lipid-Lowering Agents market covers pharmaceuticals developed to reduce levels of cholesterol and other lipids in the blood. The Other Pharmaceuticals market provides information on additional specialties that are not covered by the main markets.\n\nAdditional information:\n\nMarket values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).\n\nCompany examples: Novartis, Roche, Pfizer, Merck & Co, Johnson & Johnson, AbbVie, Sanofi."
    }
}